Update: MW just extended their tender offer, and changed the price to $65, so it looks like you can actually tender now. FYI.
Q4 EPS of $(0.38) versus the estimated $(0.13) , missing by $0.25 . Revenue came in at $560.60M versus the estimated $611.69M . Sales were Down 8% year over year.
Thank goodness for the JOSB deal. :)
You won't be able to get $65 until it closes. The arbs will keep it slightly lower until then. You can take a little less and get your money now, or wait for the tender and get full price. Up to you.
It's not going higher.
Not a chance. That only happens when there's a real chance/interest from other parties, where someone might come in and make a higher offer. In this case, both companies have agreed to a price, and there aren't any other companies that appear to want to get in. If there were, said company would have surfaced already. The deal is done. Enjoy it, and stop letting your mind get ahead of itself. :)
and a target of $4.Based mainly on predicted successful litigation with SIGA.
Woohoooooooooooooooooo!! GO PIP!
For some reason, this made me laugh. Go figure. :)
The study also showed that 22.7 percent of patients getting the drug experienced no decline in lung function, more than double the 9.7 percent seen among those taking the placebo.
Not convinced here. Still short. :)